Avalo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVTX and other ETFs, options, and stocks.About AVTX
Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders.
CEOGarry Arthur Neil
CEOGarry Arthur Neil
Employees23
Employees23
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2011
Founded2011
Employees23
Employees23
AVTX Key Statistics
Market cap38.76M
Market cap38.76M
Price-Earnings ratio-0.17
Price-Earnings ratio-0.17
Dividend yield—
Dividend yield—
Average volume65.39K
Average volume65.39K
High today$3.87
High today$3.87
Low today$3.58
Low today$3.58
Open price$3.83
Open price$3.83
Volume50.31K
Volume50.31K
52 Week high$16.00
52 Week high$16.00
52 Week low$3.39
52 Week low$3.39
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own AVTX. This list is generated using Robinhood data, and it’s not a recommendation.